Akers Biosciences, Inc. Uncategorized Contracts & Agreements
38 Contracts & Agreements
- Form of Amendment Agreement, dated as of August 8, 2024, by and among TNF Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on August 14, 2024)
- Form of Amendment Agreement, dated as of June 17, 2024, by and among MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on June 17, 2024)
- Form of Omnibus Waiver, Consent, Notice and Amendment, by and among MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on May 21, 2024)
- Form of Series F-1 Registration Rights Agreement (Filed With SEC on May 21, 2024)
- Form of Series G Registration Rights Agreement (Filed With SEC on May 21, 2024)
- Form of Series F-1 Purchase Agreement (Filed With SEC on May 21, 2024)
- Form of Series G Purchase Agreement (Filed With SEC on May 21, 2024)
- Form of Series F-1 Short-Term Warrant (Filed With SEC on May 21, 2024)
- Form of Series G Short-Term Warrant (Filed With SEC on May 21, 2024)
- Form of Series F-1 Long-Term Warrant (Filed With SEC on May 21, 2024)
- Form of Series G Long-Term Warrant (Filed With SEC on May 21, 2024)
- Form of Amendment to Warrant, dated March 14, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on May 15, 2024)
- Description of Securities (Filed With SEC on April 1, 2024)
- First Amendment to Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Christopher C. Schreiber (Filed With SEC on November 14, 2023)
- Description of Securities (Filed With SEC on March 31, 2023)
- Engagement Letter, dated February 21, 2023 by and between MyMD Pharmaceuticals, Inc. and Katalyst Securities LLC (Filed With SEC on February 21, 2023)
- Description of Securities (Filed With SEC on March 31, 2022)
- Description of Securities (Filed With SEC on March 1, 2021)
- Form of Lock-Up and Support Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and its stockholders named therein (Filed With SEC on November 12, 2020)
- Form of Lock-Up/Leak-Out Agreement (Filed With SEC on November 12, 2020)
- Rights Agreement dated as of September 9, 2020 between Akers Biosciences, Inc. and VStock Transfer, LLC as Rights Agent (Filed With SEC on September 9, 2020)
- Akers Biosciences, Inc. 2018 Plan Amendment (Filed With SEC on August 28, 2020)
- Leak-Out and Support Agreement, dated as of August 3, 2020, by and among Akers Biosciences, Inc. and ChubeWorkx Guernsey Limited (Filed With SEC on August 10, 2020)
- Description of Securities (Filed With SEC on March 25, 2020)
- Support Agreement (Filed With SEC on March 24, 2020)
- Executive Chairman Agreement, dated January 31, 2020 (Filed With SEC on January 31, 2020)
- Form of Resignation Agreement (Filed With SEC on October 12, 2018)
- Form of Resignation Agreement (Filed With SEC on October 11, 2018)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 5, 2017)
- PLACEMENTAGENCY AGREEMENT (Filed With SEC on April 5, 2017)
- UNDERWRITINGAGREEMENT Between AKERSBIOSCIENCES, INC. And JOSEPHGUNNAR & CO., LLC asRepresentative of the Several Underwriters (Filed With SEC on January 10, 2017)
- EMPLOYMENTAGREEMENT (Filed With SEC on December 3, 2015)
- LOCK-UP AGREEMENT (Filed With SEC on January 9, 2015)
- Akers Biosciences, Inc. 201 Grove Rd, West Deptford, NJ (Filed With SEC on December 6, 2013)
- AKERS BIOSCIENCES, INC. INCENTIVESTOCK OPTION AGREEMENT (Filed With SEC on December 6, 2013)
- CONTENTS (Filed With SEC on October 8, 2013)
- ANNEX SCHEDULE7: EXISTING CUSTOMERS (Filed With SEC on August 7, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 7, 2013)
